82
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Comorbidity and survival of Danish prostate cancer patients from 2000–2011: a population-based cohort study

, , , , &
Pages 47-55 | Published online: 01 Nov 2013

References

  • BorreMErichsenRLundLLarsenEHNørgaardMJacobsenJBSurvival of prostate cancer patients in central and northern Denmark, 1998–2009Clin Epidemiol20113Suppl 1414621814469
  • Cancerregisteret 2010 [Cancer Registry 2010] [webpage on the Internet]CopenhagenSundhedsstyrelsen2011 Available from: http://www.sst.dk/Udgivelser/2011/Cancerregisteret2010.aspxAccessed October 1, 2012 Danish
  • BrayFKlintAGislumMTrends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006Acta Oncol201049564465420151937
  • ReadWLTierneyRMPageNCDifferential prognostic impact of comorbidityJ Clin Oncol200422153099310315284260
  • JespersenCGNørgaardMBjerklund JohansenTESøgaardMBorreMThe influence of cardiovascular morbidity on the prognosis in prostate cancer. Experience from a 12-year nationwide Danish population-based cohort studyBMC Cancer20111151922172009
  • EpsteinMMEdgrenGRiderJRMucciLAAdamiHOTemporal trends in cause of death among Swedish and US men with prostate cancerJ Natl Cancer Inst2012104171335134222835388
  • AlbertsenPCMooreDFShihWLinYLiHLu-YaoGLImpact of comorbidity on survival among men with localized prostate cancerJ Clin Oncol201129101335134121357791
  • FitzpatrickJMManagement of localized prostate cancer in senior adults: the crucial role of comorbidityBJU Int2008101Suppl 2162218307688
  • AlibhaiSMLeachMTomlinsonG30-day mortality and major complications after radical prostatectomy: influence of age and comorbidityJ Natl Cancer Inst200597201525153216234566
  • TewariAJohnsonCCDivineGLong-term survival probability in men with clinically localized prostate cancer: a case-control, propensity modeling study stratified by race, age, treatment and comorbiditiesJ Urol200417141513151915017210
  • GroomePARohlandSLSiemensDRBrundageMDHeatonJMackillopWJAssessing the impact of comorbid illnesses on death within 10 years in prostate cancer treatment candidatesCancer2011117173943395221858801
  • AlbertsenPCFrybackDGStorerBEKolonTFFineJThe impact of co-morbidity on life expectancy among men with localized prostate cancerJ Urol199615611271328648773
  • LundLBorreMJacobsenJSørensenHTNørgaardMImpact of comorbidity on survival of Danish prostate cancer patients, 1995–2006: a population-based cohort studyUrology20087261258126218342917
  • LyngeESandegaardJLReboljMThe Danish National Patient RegisterScand J Public Health201139Suppl 7303321775347
  • SørensenHTChristensenTKjeldahlSchlosser HPedersenLUse of Medical Databases in Clinical Epidemiology2009121First EditionAarhus, DenmarkAarhus University Press
  • GammelagerHChristiansenCFJohansenMBBorreMSchoonenMSørensenHTQuality of urological cancer diagnoses in the Danish National Registry of PatientsEur J Cancer Prev201221654555122433631
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • ThygesenSKChristiansenCFChristensenSLashTLSørensenHTThe predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Med Res Methodol2011118321619668
  • HallWHJaniABRyuJKNarayanSVijayakumarSThe impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerProstate Cancer Prostatic Dis200581223015700051
  • SarfatiDReview of methods used to measure comorbidity in cancer populations: no gold standard existsJ Clin Epidemiol201265992493322739245
  • PedersenCBThe Danish Civil Registration SystemScand J Public Health201139Suppl 7222521775345
  • BrennerHRachetBHybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident casesEur J Cancer200440162494250115519525
  • Dansk Urologisk Cancer Gruppe [webpage on the Internet] Available from: www.ducg.dkAccessed August 3, 2012
  • BerglundAGarmoHTishelmanCHolmbergLStattinPLambeMComorbidity, treatment and mortality: a population based cohort study of prostate cancer in PCBaSe SwedenJ Urol2011185383383921239002
  • DaskivichTJChamieKKwanLComorbidity and competing risks for mortality in men with prostate cancerCancer2011117204642465021480201
  • FowlerJEJrTerrellFLRenfroeDLCo-morbidities and survival of men with localized prostate cancer treated with surgery or radiation therapyJ Urol19961565171417188863577
  • KetchandjiMKuoYFShahinianVBGoodwinJSCause of death in older men after the diagnosis of prostate cancerJ Am Geriatr Soc2009571243019054189
  • RiihimäkiMThomsenHBrandtASundquistJHemminkiKWhat do prostate cancer patients die of?Oncologist201116217518121257717
  • NewschafferCJOtaniKMcDonaldMKPenberthyLTCauses of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohortJ Natl Cancer Inst200092861362110772678
  • ThomasJA2ndGerberLBañezLLProstate cancer risk in men with baseline history of coronary artery disease: results from the REDUCE StudyCancer Epidemiol Biomarkers Prev201221457658122315364
  • D’AmicoAVWhittingtonRMalkowiczSBBiochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerJAMA1998280119699749749478
  • DaskivichTJFanKHKoyamaTEffect of age, tumor risk, and comorbidity on competing risks for survival in a u.s. Population-based cohort of men with prostate cancerAnn Intern Med20131581070971723689764